IO Biotech, Inc. (IOBTQ) EPS (Basic) (2020 - 2025)
IO Biotech's (IOBTQ) quarterly EPS (Basic) came in at -$0.13 in Q3 2025, up 65.67% YoY from -$0.08 in Q3 2024, and up 68.55% on a QoQ basis from -$0.4 in Q2 2025.
IO Biotech, Inc. (IOBTQ) EPS (Basic) (2020 - 2025) Analysis & Trends
IO Biotech (IOBTQ) has 6 years of EPS (Basic) data on file, last reported at -$0.13 in Q3 2025.
- Quarterly EPS (Basic) rose 65.67% year-over-year to -$0.13 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$1.32 (up 3.75% YoY) and the FY2024 annual result came in at -$1.45, up 26.69% from the prior year.
- EPS (Basic) improved to -$0.13 in Q3 2025, from -$0.4 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.13 in Q3 2025 to a low of -$228.29 in Q2 2021.
- A 5-year average of -$16.26 and a median of -$0.59 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2021 — EPS (Basic) sank 57.51% — and 2022, when it surged 99.72%.
- Tracing IOBTQ's EPS (Basic) over 5 years: stood at -$5.17 in 2021, then surged by 86.52% to -$0.7 in 2022, then advanced by 13.67% to -$0.6 in 2023, then grew by 20.91% to -$0.48 in 2024, then soared by 73.69% to -$0.13 in 2025.
- The last three EPS (Basic) figures came in at -$0.13 (Q3 2025), -$0.4 (Q2 2025), and -$0.34 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.13 |
| Jun 30, 2025 | -0.40 |
| Mar 31, 2025 | -0.34 |
| Dec 31, 2024 | -0.48 |
| Sep 30, 2024 | -0.36 |
| Jun 30, 2024 | -0.31 |
| Mar 31, 2024 | -0.30 |
| Dec 31, 2023 | -0.60 |
| Sep 30, 2023 | -0.43 |
| Jun 30, 2023 | -0.73 |
| Mar 31, 2023 | -0.59 |
| Dec 31, 2022 | -0.70 |
| Sep 30, 2022 | -0.54 |
| Jun 30, 2022 | -0.64 |
| Mar 31, 2022 | -0.60 |
| Dec 31, 2021 | -5.17 |
| Sep 30, 2021 | -36.88 |
| Jun 30, 2021 | -228.29 |
| Mar 31, 2021 | -31.53 |
| Dec 31, 2020 | -19.32 |